Pharmacovigilance Market (Drug Development: Preclinical Studies, Phase I, Phase II, Phase III, and Phase IV or Post Marketing Surveillance; Type of Methods: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, and EHR Mining; and Type of Service: In-house and Contract Outsourcing) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
Pharmacovigilance Market – Scope of Report
TMR’s report on the global pharmacovigilance market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global pharmacovigilance market for the period 2017–2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global pharmacovigilance market during the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ literature, annual reports, press releases, and relevant documents to understand the global pharmacovigilance market.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global pharmacovigilance market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global pharmacovigilance market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global pharmacovigilance market.
The report delves into the competition landscape of the global pharmacovigilance market. Key players operating in the global pharmacovigilance market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global pharmacovigilance market that have been profiled in this report.
Key Questions Answered in Pharmacovigilance Market Report
What is the scope of growth of phase of drug development companies in the global pharmacovigilance market?
What will be the Y-o-Y growth of the global pharmacovigilance market between 2019 and 2027?
What is the influence of changing trends in technologies on the global pharmacovigilance market?
Which region is likely to be the most profitable market for pharmacovigilance?
Which factors are anticipated to hamper the growth of the global pharmacovigilance market during the forecast period?
Which are the leading companies in the global pharmacovigilance market?
Research Methodology
A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global pharmacovigilance market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary methods referred to by analysts during the production of the global pharmacovigilance market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the pharmacovigilance market as primary methods.
These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the pharmacovigilance market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global pharmacovigilance market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global pharmacovigilance market more reliably and accurately.
Companies Mentioned
Accenture plc
Bristol-Myers Squibb
Clinquest Group B.V.
Cognizant
Labcorp Drug Development
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
ICON plc
iGATE Corporation
iMEDGlobal Corporation
Syneos Health
Novartis AG
PAREXEL International Corporation
Pfizer, Inc.
Pharmaceutical Phase of Drug Development, LLC. (PPD)
IQVIA
Sanofi
Synowledge LLC
Wipro Limited
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook